These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37559401)

  • 1. A Retrospective Review of Anthralin in Petrolatum in the Treatment of Alopecia Areata in the Pediatric Population.
    Zafrir Y; Tantuco K; Tangtatco AJA; Ho N
    J Cutan Med Surg; 2023; 27(5):449-453. PubMed ID: 37559401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pediatric alopecia areata with anthralin: A retrospective study of 37 patients.
    Wu SZ; Wang S; Ratnaparkhi R; Bergfeld WF
    Pediatr Dermatol; 2018 Nov; 35(6):817-820. PubMed ID: 30338548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
    Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
    Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: a pilot study.
    Sasmaz S; Arican O
    Am J Clin Dermatol; 2005; 6(6):403-6. PubMed ID: 16343028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Durdu M; Özcan D; Baba M; Seçkin D
    J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral Half-Head Comparison of 1% Anthralin Ointment in Children with Alopecia Areata.
    Özdemir M; Balevi A
    Pediatr Dermatol; 2017 Mar; 34(2):128-132. PubMed ID: 28044367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher concentrations of dithranol appear to induce hair growth even in severe alopecia areata.
    Ngwanya MR; Gray NA; Gumedze F; Ndyenga A; Khumalo NP
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28598005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review on the treatment of pediatric severe alopecia areata by topical immunotherapy or Anthralin (contact sensitization) or low-level light/laser therapy (LLLT): focus on efficacy, safety, treatment duration, recurrence, and follow-up based on clinical studies.
    Behrangi E; Roohaninasab M; Sadeghzadeh-Bazargan A; Najar Nobari N; Ghassemi M; Seirafianpour F; Goodarzi A; Dodangeh M
    J Cosmet Dermatol; 2022 Jul; 21(7):2727-2741. PubMed ID: 34606676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical immunotherapy in combination with anthralin in the treatment of refractory alopecia areata.
    Kagami S; Kishi Y; Hino H
    J Cosmet Dermatol; 2020 Sep; 19(9):2411-2414. PubMed ID: 32621407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin.
    Ibrahim SA; Esawy AM; Abdelshafy AS
    Dermatol Ther; 2019 Sep; 32(5):e13010. PubMed ID: 31237076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.
    Ghandi N; Daneshmand R; Hatami P; Abedini R; Nasimi M; Aryanian Z; Vance TM
    Int Immunopharmacol; 2021 Oct; 99():107971. PubMed ID: 34298402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.
    Hon KL; Luk DCK; Leung AKC; Ng C; Loo SKF
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(2):117-132. PubMed ID: 32723274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recalcitrant alopecia areata responsive to leflunomide and anthralin-Potentially undiscovered JAK/STAT inhibitors?
    Sardana K; Gupta A; Gautam RK
    Pediatr Dermatol; 2018 Nov; 35(6):856-858. PubMed ID: 30318623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin.
    Tang L; Cao L; Sundberg JP; Lui H; Shapiro J
    Exp Dermatol; 2004 Jan; 13(1):5-10. PubMed ID: 15009110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral treatment for alopecia areata.
    Torchia D; Schachner LA
    Pediatr Dermatol; 2010; 27(4):415-6. PubMed ID: 20653874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of anthralin in the treatment of alopecia areata.
    Fiedler-Weiss VC; Buys CM
    Arch Dermatol; 1987 Nov; 123(11):1491-3. PubMed ID: 3314718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alopecia areata.
    Perera E; Yip L; Sinclair R
    Curr Probl Dermatol; 2015; 47():67-75. PubMed ID: 26370645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin.
    Fiedler VC; Wendrow A; Szpunar GJ; Metzler C; DeVillez RL
    Arch Dermatol; 1990 Jun; 126(6):756-9. PubMed ID: 2140670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthralin therapy for alopecia areata.
    Nelson DA; Spielvogel RL
    Int J Dermatol; 1985 Nov; 24(9):606-7. PubMed ID: 3905640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alopecia areata: Part 2: treatment.
    Spano F; Donovan JC
    Can Fam Physician; 2015 Sep; 61(9):757-61. PubMed ID: 26371098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.